Neuropace Inc expected to post a loss of 32 cents a share - Earnings Preview

NeuroPace

07/05/2024 03:05

* Neuropace Inc  NPCE.OQ   NPCE.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 8 for the
period ending March 31 2024
    * The Mountain View California-based  company is expected to
report a 19.6% increase in revenue to $17.302 million from
$14.47 million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Neuropace Inc is for a
loss
of 32 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neuropace
Inc is
$19.00​, above​ its last closing price of $13.47. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.30       -0.31      -0.23     Beat    27
 Sep. 30 2023  -0.41       -0.41      -0.28     Beat    31.7
 Jun. 30 2023              -0.46      -0.36     Beat    22.6​
 Jan. 1 0001               -0.46      -0.41     Beat    10.1
 ​​Dec.        -0.50       -0.49      -0.45     Beat    9.1
 31 2022                                                
 Sep. 30 2022  -0.52       -0.53      -0.48     Beat    ​
 Jan. 1 0001   -0.44       -0.44      -0.52     Missed  -17.3
 Jan. 1 0001   -0.45       -0.44      -0.47     Missed  -6.2
 This summary was machine generated May 7 at 02:05 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)